FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This unique combination of targeting features enables CPMP’s to access and engage proteins that have long been known to play a major role in causing serious human diseases, but have been frustratingly beyond the reach of therapeutic intervention. 

Biotechnology

Pharmaceutical

FogPharma

Gregory Verdine

Ashley Kancler

John Doherty

Amanda Garofalo

Thomas Kotarako

Mathai Mammen

Lihua Yu

Keith Orford

John Mcgee

Sandra Smith

FogPharma's CEO and Executive Team includes Weiqing Zhou and 4 others.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at FogPharma

Board of Directors

Leadership Team